D
Tarsus Pharmaceuticals, Inc. TARS
$58.85 $2.243.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -20.34M -25.12M -23.11M -23.42M -33.29M
Total Depreciation and Amortization 453.00K 460.00K 432.00K 284.00K 239.00K
Total Amortization of Deferred Charges 146.00K 139.00K 138.00K 129.00K 101.00K
Total Other Non-Cash Items 6.71M 5.78M 6.09M 6.45M 8.29M
Change in Net Operating Assets -16.36M -1.91M -5.73M 7.91M 10.25M
Cash from Operations -29.39M -20.65M -22.18M -8.65M -14.40M
Capital Expenditure -1.00M -590.00K -72.00K -282.00K -1.04M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -50.70M -34.35M -59.50M 3.41M -39.49M
Cash from Investing -51.70M -34.94M -59.57M 3.13M -40.53M
Total Debt Issued -- -- 0.00 0.00 75.00M
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.95M 136.56M 2.93M 678.00K 2.68M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 -39.00K -35.36M
Cash from Financing 1.95M 136.56M 2.93M 639.00K 42.32M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -79.14M 80.97M -78.83M -4.89M -12.61M